Increasing patient access to cannabis-based medicines
Cannabinoids
5 minute read
What next for U.S. CBD Regulations and will history repeat itself?
Broughton takes a look at the FDA’s recent announcement that it is developing a regulatory assessment for CBD products in the U.S.
Filter
Filter
Results - 35 Blogs
Cannabinoids
5 minute read
Trends in Cannabis: 2022
In recent years, a growing number of countries have legalized cannabis for medicinal purposes,...
Nicotine
2 minute read
Redefining Early Stage Investments Conference Review
Pete Lomas, Managing Consultant for Product Realization, attended the Redefining Early Stage...
Sign up to our newsletter
Ensure your business stays ahead of the competition by keeping up to date on the latest regulatory changes. Sign up for our newsletter to have the latest information and insights served directly to your inbox.